We help our clients in the healthcare industries
build value for their products using four essential steps
PHMR Market Access Alerts
Your personal watchdog on the fast-moving pharmaceutical world
Our market access alerts are hand-picked items of breaking industry news. You can become a subscriber for free and receive these alerts direct to your inbox.
Our industry specific knowledge of the field allows us sort through the mass of worldwide news and go straight to the items which will affect you.
Our latest alerts direct to your inbox.
Just enter your email address below and we'll make sure you never miss out on a market access alert again.
Alternatively you can unsubscribe here.
- 12 Dec 2014 Takeda's Entyvio®, UK access to new medicines and EMA's revised conflicts of interest policy
- 3 Dec 2014 Innovative medicines review and US government proposals for disclosure of clinical trials
- 24 Nov 2014 England’s Cancer Drug Fund to reassess dozens of medicines
- 3 Nov 2014 NICE encouraged to be more favourable to industry, adaptive licensing and the ISPOR European Congress
- 24 Oct 2014 WHO proposal for clinical trial reporting within 18 months and the ACCC insists on greater transparancy
- 16 Oct 2014 NHS England consults on changes to Cancer Drug Fund (CDF)
- 16 Oct 2014 Reversal on EC's controversial plans for EMA; and Department of Health consultation